CoolCurve vs. ATX-101 for Upper Back Fat
Trial Summary
What is the purpose of this trial?
This is a prospective randomized controlled study comparing the efficacy of cryolipolysis versus ATX-101 (deoxycholic acid) for the treatment of upper back fat. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. The treatment sites are the right and left upper back fat areas. The right and left sides of the upper back fat will be randomly assigned (1:1) to receive cryolipolysis, while the contralateral side will receive ATX-101. This study was a pilot study designed to determine feasibility of this procedure.
Research Team
Murad Alam, MD
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for adults over 18 in good health with mild to moderate upper back fat, living in the Chicago area. They must understand and consent to participate. Excluded are those with cold-induced diseases, scar issues, pregnancy, breastfeeding, neurological disorders affecting cooperation or understanding of the protocol, and anyone on antiplatelet/anticoagulant therapy or with coagulation disorders.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- ATX-101
- CoolCurve
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor